AYTU
AYTU BIOPHARMA, INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.90
−4.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 7.35x
- P/S forward
- 0.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.59x
- Price / sales
- 0.36x
- Price / cash flow
- 6.29x
Enterprise value
- Enterprise value
- $12.4M
- EV / sales
- 0.22x
- EV / EBITDA
- -1.47x
- EV / EBIT
- -1.50x
- Market cap
- $20.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026